Astellas Pharma Inc R&D Meeting Transcript
Now we'll start the presentation. Next slide, please. Good afternoon, everyone. This is Okamura. I'm quite sure that you are all busy, but thank you very much for your participation in this R&D meeting. In this October, our organization has changed. So today, we would like to introduce a new research organization structure.
Next slide, please. This is the caution statement for this meeting. Definitely, you already read about this. I would like to skip.
Next slide, please. Agenda for today. First, I will introduce the background of this reorganization and then Dr. Shitaka will explain the details.
Next slide, please. Next. In the CSP Corporate Strategy Plan 2021 that we announced in May this year, in order to show how Astellas will overcome the XTANDI patent cliff and achieve sustainable growth we presented mid- to long-term goals that extend beyond, 2027 when the patent expires, 2030. So as a result, we believe that our current vision for
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
